Article in Biology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Linda SerraDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy.
Anna NordinWallenberg Centre for Molecular Medicine, Linköping University, SE-581 83 Linköping, Sweden.
Mattias JonassonWallenberg Centre for Molecular Medicine, Linköping University, SE-581 83 Linköping, Sweden.ORCID 0000-0001-5528-3405
Carolina MarencoDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy.
Guido RovelliDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy.
Annika DiebelsDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy.
Francesca GulloDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy.
Sergio OttolenghiDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy.
Federico ZambelliDepartment of Biosciences, University of Milano, 20133 Milano, Italy.
Michèle StuderUniversité Côte d'Azur, CNRS, Inserm, Institute of Biology Valrose (iBV), 06108 Nice, France.ORCID 0000-0001-7105-2957
Giulio PavesiDepartment of Biosciences, University of Milano, 20133 Milano, Italy.
Claudio CantùWallenberg Centre for Molecular Medicine, Linköping University, SE-581 83 Linköping, Sweden.ORCID 0000-0003-1547-5415
Silvia K NicolisDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy.ORCID 0000-0003-0378-3808
Sara MercurioDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126 Milano, Italy.ORCID 0000-0003-3469-8323
Funding
Additional Ventures SVRF2021-1048003Cancerfonden 21 1572 PjCancerfonden 21 1572 Pj and 24 3487 Pj 01 HCancerfonden 24 3487 Pj 01 HEU ERANET-NEURON Brain4SightFondazione Cariplo GJC21176Fondazione Telethon GMR23T1022Fondazione Telethon-Fondazione Cariplo Alliance GJC21176Knut and Alice Wallenberg FoundationKnut och Alice Wallenbergs Stiftelse 2018-2024Linköping UniversityMinistero dell'Universita' e della Ricerca (MUR) H53D23003020001Ministero dell'Universita' e della Ricerca (MUR) PRIN 2022 CUPPRIN Next Generation EU, Missione 4 Componente 1, CUP H53D23003020001Science for Life LaboratoryVetenskapsradet 2021-03075 and 2023-01898Vetenskapsrådet 2021-03075Vetenskapsrådet 2023-01898
6 · The paper itself
Abstract
The thalamic dorsolateral geniculate nucleus (dLGN) receives visual input from the retina via the optic nerve, and projects to the cortical visual area, where eye-derived signals are elaborated. The transcription factors SOX2 and NR2F1 are directly involved in the differentiation of dLGN neurons, based on mouse work and patient mutations leading to vision defects. However, whether they regulate each other, or control common targets is still unclear. By RNA-seq analysis of neonatal dLGN from thalamo-specific Sox2 and Nr2f1 mouse mutants, we found a striking overlap of deregulated genes. Among them, Vgf, encoding a cytokine transported along thalamic-cortical axons is strongly downregulated in both mutants. Direct SOX2 binding to some of these genes was confirmed by CUT&RUN, which identified a SOX2 chromatin-binding pattern characteristic of the dLGN. Collectively, our genetic and molecular analyses on the SOX2 and NR2F1-coregulated genes contribute to our understanding of the gene regulatory network driving the differentiation and connectivity of thalamic neurons, and the vision impairments caused by mutations in these genes.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
SOX2 and NR2F1 coordinate the gene expression program of the early postnatal visual thalamus. · full record | OpenQuestion